Charmaine Roson - Philippines

The workshop brought together public and private medical device regulatory professionals from throughout Southeast Asia to try to find a model that would work to balance the safety and quality of medical devices but also ensure regulators and stakeholders in the field have adequate capacity to look after all the complex aspects.”

Charmaine Roson
Principal Consultant
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

USAID, ANSI and AdvaMed Host Regional Virtual Workshop on Good Regulatory Practices and Medical Device Regulation

Published on: March 7th, 2023

USAID, ANSI, and AdvaMed have partnered to host a two-day Virtual Regional Workshop on Good Regulatory Practices and Medical Device Regulation, which took place from February 28 to March 1, 2023. The workshop was designed to provide attendees with the necessary knowledge and skills to navigate the complex and ever-changing world of medical device regulation.

Representatives from Asia Actual Philippines, Karla Justo, and Charmaine Roson, were in attendance at the virtual event. The workshop covered a wide range of topics, including the WTO TBT standards, regulatory cooperation, and coherence tools. Attendees were also educated on the benefits of recognizing foreign conformity assessment results, transparency, predictability, inclusion, consistency, and accountability.

The first day of the workshop saw discussions on specific GRPS such as public consultation, internal cooperation, and making smart decisions based on the best available science and data. Participants examined updates to the WHO Global model regulatory framework for medical devices, including IVDs, as well as fundamental ideas for WHO good reliance and the functions of the IMDRF. Indonesia shared its views on medical device regulation in accordance with International Standards and the AMDD. The importance of convergence in accelerating access to safe and effective products and improving health outcomes was also discussed.

Discussions on Reliance Models and Post-Market Surveillance

On the second day of the workshop, individual country experience with reliance models, including the common dossier template, was discussed. The panel was moderated by Seet Wing Gang, Director of Regulatory Affairs at Cook Medical, with panelists from the US Food and Drug Administration, Health Sciences Authority, Philippine FDA, and FDA Thailand. The workshop also covered the requirements for post-market surveillance and market surveillance of medical devices, including in vitro diagnostics.

The workshop was a great opportunity for regulators and stakeholders in the medical device industry to collaborate and find ways to uphold medical device safety and standards. Discussions also centered around the implications of these guidelines and the responsibility of manufacturers. By the end of the workshop, attendees left with a deeper understanding of the medical device regulatory landscape and how to navigate it.

To learn more about the medical device registration process in the Philippines, please click here.

To learn more about the new expedited market access (Reliance Route) option in the Philippines, please click here.

Grow With Us

Please contact us if you’d like to learn more about expedited market access options in the Philippines or other markets in the region. Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests. 

Asia Actual is a regulatory consulting company focused on helping manufacturers grow sales in challenging Asia markets through independent license holding, direct fulfillment, and a variety of sales channel support services.   

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.